Synovial sarcoma armoury boosted as OncoTherapy antibody enters clinic
This article was originally published in Scrip
Executive Summary
OncoTherapy Science (OTS) will soon begin the clinical development of a novel monoclonal antibody therapy against synovial sarcoma, a rare form of malignancy with few existing treatment options.